Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-05-29

Clinical Trial Update: MK0507A Clinical Study in Patients With Glaucoma and Ocular Hypertension (0507A-149)(COMPLETED) [Phase 3]

View source ↗

Summary

Phase 3 study MK0507A in glaucoma (and ocular hypertension) completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MK0507A

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Glaucoma | Phase 3 | Status: COMPLETED | Results posted: 2009-05-29